CL2007002285A1 -
COMPOUNDS DERIVED FROM MACROCICLIC PIRIDAZINYL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A VIRAL INFECTION OF HEPATITIS C.
- Google Patents
COMPOUNDS DERIVED FROM MACROCICLIC PIRIDAZINYL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A VIRAL INFECTION OF HEPATITIS C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm IncfiledCriticalEnanta Pharm Inc
Publication of CL2007002285A1publicationCriticalpatent/CL2007002285A1/en
CL2007002285A2006-08-042007-08-06
COMPOUNDS DERIVED FROM MACROCICLIC PIRIDAZINYL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A VIRAL INFECTION OF HEPATITIS C.
CL2007002285A1
(en)
Compounds derived from 3-phenylpyridin-2-one, viral RNA dependent rna polymerase inhibitors; pharmaceutical composition comprising said compounds; and its use for the treatment of a disease caused by the hepatitis c virus.
Macrocyclic compounds, combinations and pharmaceutical compositions comprising them, uses thereof as inhibitors of hepatitis c virus and processes for their preparation
Compounds derived from 2-aryl-substituted-1-benzofuran-3-carboxamide, ns5b polymerase inhibitors; pharmaceutical composition; and its use in the treatment of a disease caused by the hepatitis c virus (hcv).
PARASITICIDE COMPOUNDS DERIVED FROM SUBSTITUTED ARIL-PIRAZOLES; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A PARASITARY INFECTION.
COMPOUNDS DERIVED FROM 6-AMINO-PURIN-8-ONA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCESS TO PREPARE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF ALLERGIC, VIRAL OR CANCER DISEASES.
Compounds derived from substituted nucleosides, nucleotides and analogs thereof; pharmaceutical composition; and use to improve or treat a viral infection.
Benzimidazole-imidazole derivative compounds, hepatitis c virus (hcv) inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; use in the prevention or treatment of hcv infection.
Crystalline forms of a compound derived from 2-thiazolyl-4-quinolinyl-oxy; Sodium salt of the compound, pharmaceutical composition comprising sodium salt, useful for treating hepatitis C virus infection.
COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
COMPOUNDS DERIVED FROM REPLACED DIHYDROPIRIDINES; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; PROCESS TO PRODUCE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A DISEASE IMPROVED WITH INHIBITION
compounds of formulas (i) and (ii), method of treating hiv-1, hiv-2, hbv or hcv infected host, method of preventing hiv-1, hiv-2, hbv or hcv infection, method for reduce biological activity of hiv-1, hiv-2, hbv or hcv infection and pharmaceutical composition
Compounds derived from macrocyclic prolines, inhibitors of hepatitis C virus serine proteases (vhc); pharmaceutical composition that includes them; and its use to treat a viral infection such as hepatitis C virus (vhc) infection.
Compounds derived from tripeptides containing nitrogen heterocycles; pharmaceutical composition comprising said compounds; and use to treat a hepatitis c or hiv infection.
COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 4 AND 5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION.
COMPOUNDS DERIVED FROM QUINOLINA; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMBINATION; AND USE OF COMPOUNDS TO PREPARE A MEDICINAL PRODUCT TO TREAT BACTERIAL INFECTION.